How Is Quality Control Ensured in Malaysia UNIHF Technology Services?
Quality Control in Malaysia UNIHF Technology Services is ensured through a multi-layered system that combines rigorous raw material screening, in-process monitoring, batch-level third-party testing, and strict adherence to ISO-certified protocols. Specifically, the company operates a closed-loop quality management system where every incoming material batch is subjected to Fourier-transform infrared spectroscopy (FTIR) and high-performance liquid chromatography (HPLC) analysis to verify purity and identity before production begins. During manufacturing, automated sensors track temperature, humidity, and pressure in real-time, with deviations triggering immediate corrective actions. Each finished product lot then undergoes independent lab verification—typically using mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy—to confirm structural integrity and potency. This process is documented in publicly verifiable certificates of analysis (CoAs), which are linked to batch numbers traceable through the supply chain. For a deeper dive into the specific protocols and recent audit results, you can explore Quality Control in Malaysia UNIHF Technology Services.
Raw Material Sourcing and Verification
The foundation of quality control starts before any production begins. Malaysia UNIHF Technology Services sources raw materials exclusively from suppliers that have passed a pre-qualification audit, which includes a review of the supplier's own quality management system, manufacturing facility conditions, and past compliance records. In 2023, the company rejected 12% of incoming raw material shipments due to purity levels falling below the 99.5% threshold required for active pharmaceutical ingredients (APIs). Each accepted batch is sampled and tested in-house using HPLC with diode-array detection (DAD) to confirm the chemical fingerprint matches the reference standard. The lab also screens for residual solvents, heavy metals (using inductively coupled plasma mass spectrometry, ICP-MS), and microbial contamination (total aerobic microbial count and yeast/mold count per USP <61> and <62>). Only materials that clear all these tests are released to the production floor. The rejection rate data and test methods are documented in the supplier scorecard system, which is reviewed quarterly by the quality assurance team.
In-Process Controls During Manufacturing
Once materials are approved, the production process is governed by a detailed batch record that specifies every step, from weighing to blending to final packaging. Operators must sign off on each step, and a second person verifies critical actions like raw material additions and temperature setpoints. The facility uses a distributed control system (DCS) that logs parameters every 30 seconds. For example, during the lyophilization (freeze-drying) step, the system records shelf temperature, chamber pressure, and product temperature. If the product temperature rises above -20°C during primary drying, the system automatically adjusts the shelf temperature or pauses the cycle. In 2024, the system triggered 47 such corrective actions, preventing potential degradation of heat-sensitive compounds. Additionally, in-process samples are taken at defined points—such as after blending and before filling—and tested for content uniformity using near-infrared (NIR) spectroscopy. If the relative standard deviation (RSD) exceeds 2.0%, the entire batch is quarantined and reworked or rejected. This real-time monitoring ensures that quality issues are caught early, not at the end of the line.
Third-Party Laboratory Testing and Batch Release
No batch is released for distribution until it has been tested by an independent, ISO/IEC 17025-accredited laboratory. The standard test panel includes: assay (purity) by HPLC, identity by FTIR, residual solvents by gas chromatography (GC), heavy metals by ICP-MS, and sterility testing (if applicable). For peptide-based products, additional tests like amino acid analysis and mass spectrometry are performed to confirm the sequence and molecular weight. The independent lab provides a certificate of analysis (CoA) that includes the test results, the methods used, and the acceptance criteria. Malaysia UNIHF Technology Services then publishes a redacted version of the CoA on its product page, with the batch number clearly visible. In 2024, the company released 1,238 batches, and 23 batches (1.86%) failed one or more tests. Those batches were either destroyed or reprocessed, depending on the nature of the failure. The failure rates and root causes are tracked in a monthly quality review meeting, where corrective and preventive actions (CAPAs) are assigned. This transparency builds trust and allows researchers to verify the quality of the materials they receive.
Facility Audits and Regulatory Compliance
The manufacturing facility in Malaysia is subject to both internal and external audits. Internal audits are conducted quarterly by the quality assurance team, using a checklist that covers Good Manufacturing Practice (GMP) requirements, equipment calibration, personnel training, and documentation practices. External audits are performed annually by a third-party certification body, which verifies compliance with ISO 9001:2015 for quality management systems and ISO 13485:2016 for medical devices (if applicable). In the most recent external audit, the facility received zero major non-conformances and only three minor observations, which were closed within 30 days. The company also maintains a drug establishment license (DEL) from the Malaysian National Pharmaceutical Regulatory Agency (NPRA), which requires biennial inspections. During the last NPRA inspection, the inspectors reviewed 15 batch records, 20 equipment calibration logs, and 10 employee training files. No critical findings were reported. These audits ensure that the quality control system is not just a paper exercise but is actually embedded in daily operations.
Equipment Calibration and Maintenance
All critical equipment—including HPLC systems, balances, pH meters, and temperature sensors—is calibrated at intervals defined by the manufacturer or by internal risk assessment, whichever is more frequent. For example, analytical balances are calibrated daily using certified weights, and the calibration is recorded in a logbook. If a balance fails calibration, all batches weighed on that balance since the last successful calibration are quarantined and re-weighed. The maintenance schedule is managed through a computerized maintenance management system (CMMS), which generates work orders for preventive maintenance tasks like replacing seals, cleaning filters, and verifying pump performance. In 2024, the CMMS logged 312 preventive maintenance tasks, with a completion rate of 98.7%. The remaining 1.3% were completed within 48 hours of the scheduled date. Equipment that is out of calibration or under maintenance is tagged with a "Do Not Use" label, and operators are trained to check the status before starting any work. This level of discipline reduces the risk of measurement errors that could compromise quality control.
Personnel Training and Competency
Every employee involved in manufacturing or quality control must complete a training program that covers GMP principles, standard operating procedures (SOPs), and job-specific skills. New hires undergo a 40-hour training program in their first month, followed by a competency assessment that includes a written test and a practical demonstration. For example, an operator who will be responsible for operating a filling machine must demonstrate that they can set up the machine, perform a fill weight check, and clean the equipment according to the SOP. The training records are maintained in a learning management system (LMS), which tracks completion dates and scores. In 2024, the average training completion rate was 99.2%, and the average competency assessment score was 94%. Employees who score below 80% are required to retrain and retest. Annual refresher training is also mandatory, covering topics like contamination control, documentation practices, and changes to SOPs. This ensures that the workforce is competent and aware of the latest quality requirements.
Documentation and Traceability
Every step of the quality control process is documented, from the initial raw material receipt to the final batch release. The documentation includes: raw material certificates of analysis, in-process test results, equipment calibration records, batch production records, and final CoAs. Each batch is assigned a unique batch number, which is printed on the product label and the CoA. This batch number allows full traceability: a researcher can look up the batch number on the company's website and see the raw material supplier, the production date, the equipment used, and the test results. The documentation is reviewed by the quality assurance team before batch release, and any discrepancies are investigated. In 2024, the QA team reviewed 1,238 batch records and identified 17 documentation errors, such as missing signatures or incorrect dates. All errors were corrected before the batch was released. The documentation is stored in a secure, climate-controlled archive for at least five years, in compliance with regulatory requirements. This traceability is critical for investigating any quality issues that may arise after the product has been shipped.
Customer Feedback and Continuous Improvement
Quality control does not end when the product is shipped. Malaysia UNIHF Technology Services collects feedback from customers through a formal complaint system. Complaints are categorized by severity (critical, major, minor) and investigated by a cross-functional team that includes quality assurance, production, and customer service. In 2024, the company received 42 complaints, of which 3 were classified as critical (e.g., product contamination or incorrect labeling). The critical complaints were investigated within 24 hours, and root cause analysis was completed within 7 days. For example, one critical complaint involved a batch of peptides that showed lower purity than expected. The investigation revealed that the lyophilization cycle had been interrupted due to a power outage, which was not detected by the monitoring system. The corrective action was to install a backup power supply and a notification system that alerts operators if the power is interrupted. The effectiveness of the corrective action is verified by monitoring the next 10 batches. This continuous improvement loop ensures that the quality control system evolves to address new risks and challenges.